Angiodynamics (ANGO) Divestments (2023 - 2024)
Angiodynamics' (ANGO) quarterly Divestments came in at $34.5 million in Q1 2024, down 65.5% quarter-over-quarter from $100.0 million in Q3 2023.
Powered by 
Analysis
Angiodynamics (ANGO) Divestments (2023 - 2024) Analysis & Trends
Angiodynamics (ANGO) has reported Divestments for 2 consecutive years, with $34.5 million the latest figure, recorded in Q1 2024.
- For the quarter ending Q1 2024, Divestments changed N/A year-over-year to $34.5 million; the trailing twelve-month figure through Nov 2024 stood at $34.5 million (down 65.5% YoY), and the FY2024 full-year result was $134.5 million, changed N/A from the prior year.
- Divestments declined to $34.5 million in Q1 2024 per ANGO's latest filing, from $100.0 million in the prior quarter.
- Across five years, Divestments topped out at $100.0 million in Q3 2023 and bottomed at $34.5 million in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.32 Bn | 122.10 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.97 Bn | 100.50 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.66 Bn | 63.12 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.00 Bn | 31.54 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.04 Bn | 30.09 Bn | 830.00 Mn | - |
| 9 | Steris | 20.70 Bn | 20.22 Bn | 684.20 Mn | - |
| 10 | Angiodynamics | 626.63 Mn | 572.76 Mn | 46.77 Mn | - |